Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5894)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 26, 2023 (publication date) through Feb 16, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Yang YJ, Xu XQ, Zhang YC, Hu PC, Yang WX. Establishment of a prognostic model related to tregs and natural killer cells infiltration in bladder cancer. World J Clin Cases 2023; 11(15): 3444-3456 [PMID: 37383920 DOI: 10.12998/wjcc.v11.i15.3444] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Yang YJ, Xu XQ, Zhang YC, Hu PC, Yang WX. Establishment of a prognostic model related to tregs and natural killer cells infiltration in bladder cancer. World J Clin Cases 2023; 11(15): 3444-3456 [PMID: 37383920 DOI: 10.12998/wjcc.v11.i15.3444] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i15/3444.htm |
| Number | Citing Articles |
| 1 |
Fu Yu, Li Zhao, Shangqi Chu. TCHH as a Novel Prognostic Biomarker for Patients with Gastric Cancer by Bioinformatics Analysis. Clinical and Experimental Gastroenterology 2024; : 61 doi: 10.2147/CEG.S451676
|
| 2 |
Melinda Lillesand, Vebjørn Kvikstad, Einar Gudlaugsson, Ivar Skaland, Aida Slewa Johannessen, Almaz Nigatu Tesfahun, Sigmund Vegard Sperstad, Emiel A. M. Janssen, Marie Austdal. Integrating Genetic Alterations and Histopathological Features for Enhanced Risk Stratification in Non-Muscle-Invasive Bladder Cancer. Diagnostics 2024; 14(19): 2137 doi: 10.3390/diagnostics14192137
|
| 3 |
Isaac E. Kim, Cliff Oduor, Julian Stamp, Micah A. Luftig, Ann M. Moormann, Lorin Crawford, Jeffrey A. Bailey. Incorporation of Epstein–Barr viral variation implicates significance of Latent Membrane Protein 1 in survival prediction and prognostic subgrouping in Burkitt lymphoma. International Journal of Cancer 2025; 156(11): 2188 doi: 10.1002/ijc.35384
|
| 4 |
Li Yan, Pengxiao Su, Xiaoke Sun. Role of the tumor microenvironment in promoting treatment resistance in urothelial carcinoma (Review). Molecular Medicine Reports 2025; 32(5): 1 doi: 10.3892/mmr.2025.13658
|
| 5 |
Junhao Chen, Yuanzhi Fu, Zhongsong Zhang, Junxian Zhao, Jieming Zuo, Xinni Ye, Qiao Xiong, Zuqing Nie, Haonan Dong, Hongjin Shi, Zhiyong Tan, Chengjie Wang, Bo Chen, Zhengyan Wang, Xiangyun Li, Peng Chen, Haifeng Wang, Shi Fu. Nanomaterial-Enhanced Immunotherapy: Advancing T-Cell-Based Treatments for Bladder Cancer. International Journal of Nanomedicine 2025; : 15235 doi: 10.2147/IJN.S557690
|